| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ethanol | 34 | 2023 | 1337 | 3.770 |
Why?
|
| Neural Cell Adhesion Molecule L1 | 9 | 2018 | 40 | 2.160 |
Why?
|
| Cell Adhesion | 18 | 2019 | 3139 | 1.620 |
Why?
|
| Central Nervous System Depressants | 5 | 2018 | 167 | 1.030 |
Why?
|
| Ankyrins | 2 | 2019 | 128 | 0.840 |
Why?
|
| Lactams | 1 | 2022 | 155 | 0.820 |
Why?
|
| Leucine | 1 | 2022 | 560 | 0.760 |
Why?
|
| Ritonavir | 1 | 2022 | 322 | 0.750 |
Why?
|
| Proline | 1 | 2022 | 458 | 0.750 |
Why?
|
| Dystonic Disorders | 4 | 2013 | 329 | 0.690 |
Why?
|
| Alcohol-Related Disorders | 1 | 2022 | 234 | 0.690 |
Why?
|
| Alcoholism | 7 | 2022 | 1904 | 0.690 |
Why?
|
| Telemedicine | 5 | 2024 | 2853 | 0.690 |
Why?
|
| Adolescent Development | 2 | 2019 | 277 | 0.620 |
Why?
|
| Nasopharynx | 1 | 2020 | 379 | 0.610 |
Why?
|
| Nitriles | 1 | 2022 | 952 | 0.600 |
Why?
|
| Oligopeptides | 7 | 2011 | 1176 | 0.590 |
Why?
|
| Prenatal Exposure Delayed Effects | 6 | 2023 | 2407 | 0.500 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2020 | 783 | 0.480 |
Why?
|
| Occupational Diseases | 3 | 2021 | 1472 | 0.470 |
Why?
|
| Health Personnel | 3 | 2023 | 3210 | 0.470 |
Why?
|
| Transforming Growth Factor beta | 7 | 2000 | 2006 | 0.470 |
Why?
|
| Membrane Microdomains | 1 | 2014 | 202 | 0.460 |
Why?
|
| Advisory Committees | 1 | 2017 | 773 | 0.460 |
Why?
|
| Music | 4 | 2004 | 259 | 0.450 |
Why?
|
| Glial Cell Line-Derived Neurotrophic Factor | 1 | 2012 | 65 | 0.430 |
Why?
|
| 1-Octanol | 2 | 2002 | 7 | 0.430 |
Why?
|
| Neural Cell Adhesion Molecules | 5 | 2001 | 126 | 0.420 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 4 | 1994 | 265 | 0.410 |
Why?
|
| Bone Morphogenetic Proteins | 7 | 2000 | 838 | 0.410 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2013 | 489 | 0.390 |
Why?
|
| Alcohol Drinking | 6 | 2023 | 3957 | 0.370 |
Why?
|
| Antiviral Agents | 1 | 2022 | 2978 | 0.360 |
Why?
|
| src-Family Kinases | 1 | 2012 | 551 | 0.350 |
Why?
|
| Nerve Growth Factors | 1 | 2012 | 576 | 0.350 |
Why?
|
| NIH 3T3 Cells | 5 | 2018 | 677 | 0.340 |
Why?
|
| Neurons | 9 | 2012 | 9325 | 0.340 |
Why?
|
| Alcohols | 4 | 2007 | 92 | 0.330 |
Why?
|
| National Institute on Alcohol Abuse and Alcoholism (U.S.) | 2 | 2022 | 10 | 0.310 |
Why?
|
| Thalamus | 1 | 2013 | 1023 | 0.300 |
Why?
|
| Attitude of Health Personnel | 1 | 2021 | 3839 | 0.300 |
Why?
|
| Axons | 2 | 2012 | 1681 | 0.290 |
Why?
|
| Homeodomain Proteins | 2 | 2008 | 2417 | 0.290 |
Why?
|
| Wernicke Encephalopathy | 3 | 1999 | 28 | 0.280 |
Why?
|
| Brain | 8 | 2019 | 26343 | 0.260 |
Why?
|
| Proto-Oncogene Proteins c-fos | 2 | 2000 | 575 | 0.260 |
Why?
|
| 3T3 Cells | 6 | 2004 | 1101 | 0.250 |
Why?
|
| Nerve Tissue Proteins | 3 | 2008 | 4465 | 0.250 |
Why?
|
| Dystonia | 4 | 1997 | 363 | 0.250 |
Why?
|
| Teratogens | 3 | 2001 | 112 | 0.250 |
Why?
|
| Leukocyte L1 Antigen Complex | 7 | 2001 | 88 | 0.250 |
Why?
|
| Biomedical Research | 2 | 2018 | 3306 | 0.240 |
Why?
|
| Pregnancy | 14 | 2023 | 29087 | 0.220 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2012 | 2842 | 0.210 |
Why?
|
| Bone Morphogenetic Protein 7 | 6 | 2000 | 112 | 0.200 |
Why?
|
| Receptors, Opioid | 3 | 1989 | 155 | 0.200 |
Why?
|
| Embryo, Mammalian | 3 | 2004 | 1692 | 0.200 |
Why?
|
| Proteins | 5 | 1995 | 6096 | 0.200 |
Why?
|
| Residential Facilities | 1 | 2021 | 43 | 0.200 |
Why?
|
| Abnormalities, Drug-Induced | 2 | 2006 | 316 | 0.200 |
Why?
|
| Crk-Associated Substrate Protein | 2 | 2012 | 41 | 0.200 |
Why?
|
| Humans | 66 | 2024 | 742088 | 0.190 |
Why?
|
| Genes, fos | 1 | 2000 | 183 | 0.180 |
Why?
|
| Cognition | 1 | 2017 | 6722 | 0.180 |
Why?
|
| Animals | 42 | 2020 | 168561 | 0.180 |
Why?
|
| Korsakoff Syndrome | 1 | 1999 | 18 | 0.180 |
Why?
|
| Mice | 24 | 2020 | 81045 | 0.180 |
Why?
|
| United States Department of Veterans Affairs | 2 | 2021 | 874 | 0.180 |
Why?
|
| Neuroprotective Agents | 2 | 2005 | 941 | 0.180 |
Why?
|
| Cerebellum | 3 | 2012 | 1490 | 0.170 |
Why?
|
| Ulnar Nerve | 2 | 1996 | 109 | 0.170 |
Why?
|
| 1-Butanol | 2 | 2011 | 13 | 0.160 |
Why?
|
| Mental Health | 2 | 2022 | 2997 | 0.150 |
Why?
|
| Spectrin | 1 | 2018 | 177 | 0.150 |
Why?
|
| Dissociative Disorders | 1 | 2019 | 231 | 0.150 |
Why?
|
| Drug Combinations | 1 | 2022 | 1961 | 0.150 |
Why?
|
| Structure-Activity Relationship | 4 | 2004 | 3133 | 0.140 |
Why?
|
| Rats | 15 | 2012 | 24265 | 0.140 |
Why?
|
| Cell Line | 9 | 2014 | 15994 | 0.140 |
Why?
|
| Specialties, Surgical | 1 | 2021 | 389 | 0.140 |
Why?
|
| Brain Mapping | 2 | 2019 | 6669 | 0.140 |
Why?
|
| Molecular Chaperones | 1 | 2000 | 742 | 0.140 |
Why?
|
| Receptors, Opioid, delta | 2 | 1993 | 47 | 0.130 |
Why?
|
| Supraoptic Nucleus | 1 | 1995 | 28 | 0.130 |
Why?
|
| Specimen Handling | 1 | 2020 | 692 | 0.130 |
Why?
|
| Receptors, Adrenergic, alpha | 2 | 1993 | 149 | 0.130 |
Why?
|
| Peptides | 3 | 2019 | 4392 | 0.130 |
Why?
|
| Delivery of Health Care | 2 | 2024 | 5304 | 0.130 |
Why?
|
| Peptide Fragments | 2 | 2007 | 5095 | 0.120 |
Why?
|
| Eye Abnormalities | 2 | 2007 | 246 | 0.120 |
Why?
|
| Electric Injuries | 1 | 1994 | 26 | 0.120 |
Why?
|
| Infection Control | 1 | 2021 | 962 | 0.120 |
Why?
|
| Phosphorylation | 4 | 2018 | 8436 | 0.120 |
Why?
|
| Supranuclear Palsy, Progressive | 1 | 1994 | 77 | 0.120 |
Why?
|
| Fingers | 2 | 1996 | 514 | 0.120 |
Why?
|
| Ophthalmoplegia | 2 | 1992 | 166 | 0.120 |
Why?
|
| Basal Ganglia Diseases | 1 | 1994 | 149 | 0.110 |
Why?
|
| Wakefulness | 1 | 2000 | 1243 | 0.110 |
Why?
|
| Receptors, Muscarinic | 1 | 1993 | 156 | 0.110 |
Why?
|
| Cross Infection | 1 | 2022 | 1413 | 0.110 |
Why?
|
| Amino Acid Substitution | 2 | 2011 | 1792 | 0.110 |
Why?
|
| Gene Deletion | 1 | 2000 | 2751 | 0.110 |
Why?
|
| Ocular Motility Disorders | 1 | 1994 | 135 | 0.110 |
Why?
|
| Sodium Chloride | 1 | 1995 | 625 | 0.110 |
Why?
|
| Cell Differentiation | 2 | 2008 | 11470 | 0.110 |
Why?
|
| Cell Aggregation | 1 | 1992 | 244 | 0.110 |
Why?
|
| Pandemics | 2 | 2023 | 8328 | 0.110 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 1995 | 514 | 0.110 |
Why?
|
| Leg Injuries | 1 | 1994 | 178 | 0.100 |
Why?
|
| Brain Damage, Chronic | 1 | 1993 | 265 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 8 | 2018 | 21821 | 0.100 |
Why?
|
| Female | 27 | 2023 | 379592 | 0.100 |
Why?
|
| Cells, Cultured | 6 | 2012 | 19223 | 0.100 |
Why?
|
| History, 21st Century | 1 | 2018 | 1533 | 0.100 |
Why?
|
| National Institute on Drug Abuse (U.S.) | 1 | 2011 | 11 | 0.100 |
Why?
|
| Massachusetts | 2 | 2021 | 8662 | 0.100 |
Why?
|
| Mercaptoethanol | 1 | 2011 | 64 | 0.100 |
Why?
|
| Fatty Alcohols | 1 | 2011 | 23 | 0.100 |
Why?
|
| Membrane Glycoproteins | 3 | 2001 | 3769 | 0.100 |
Why?
|
| Retinal Artery Occlusion | 1 | 1991 | 74 | 0.100 |
Why?
|
| Hand Injuries | 1 | 1994 | 242 | 0.100 |
Why?
|
| GTP-Binding Proteins | 3 | 1993 | 970 | 0.100 |
Why?
|
| Recurrence | 1 | 2022 | 8333 | 0.090 |
Why?
|
| History, 20th Century | 2 | 2018 | 2739 | 0.090 |
Why?
|
| Nitroglycerin | 1 | 1991 | 325 | 0.090 |
Why?
|
| Chickens | 1 | 2012 | 865 | 0.090 |
Why?
|
| Blepharoptosis | 1 | 1991 | 144 | 0.090 |
Why?
|
| Signal Transduction | 5 | 2018 | 23387 | 0.090 |
Why?
|
| Animals, Newborn | 2 | 2012 | 2723 | 0.090 |
Why?
|
| Nervous System Diseases | 3 | 1998 | 1617 | 0.090 |
Why?
|
| Social Stigma | 1 | 2016 | 698 | 0.090 |
Why?
|
| Vaccination | 1 | 2021 | 3256 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 8 | 2007 | 10943 | 0.090 |
Why?
|
| Social Environment | 1 | 2014 | 1023 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-fyn | 1 | 2008 | 116 | 0.080 |
Why?
|
| Calcium-Binding Proteins | 1 | 1993 | 1081 | 0.080 |
Why?
|
| United States | 6 | 2022 | 69693 | 0.080 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2022 | 3014 | 0.080 |
Why?
|
| Veterans | 1 | 2022 | 2513 | 0.080 |
Why?
|
| Disease Management | 1 | 2019 | 2450 | 0.080 |
Why?
|
| Butanols | 1 | 2007 | 19 | 0.080 |
Why?
|
| Mutation, Missense | 2 | 2011 | 2556 | 0.080 |
Why?
|
| Incidence | 4 | 2021 | 20928 | 0.080 |
Why?
|
| Survival Analysis | 1 | 2021 | 10248 | 0.080 |
Why?
|
| Fibroblasts | 1 | 1998 | 4143 | 0.080 |
Why?
|
| Diazomethane | 1 | 2007 | 36 | 0.080 |
Why?
|
| Maternal Exposure | 1 | 2014 | 961 | 0.080 |
Why?
|
| Giant Cell Arteritis | 1 | 1991 | 292 | 0.080 |
Why?
|
| Enzyme Activation | 2 | 2012 | 3701 | 0.080 |
Why?
|
| Spinal Cord Diseases | 1 | 1990 | 299 | 0.070 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2011 | 780 | 0.070 |
Why?
|
| Alcoholic Intoxication | 2 | 1989 | 188 | 0.070 |
Why?
|
| Carrier Proteins | 1 | 2000 | 5019 | 0.070 |
Why?
|
| Muscle Cramp | 2 | 1997 | 35 | 0.070 |
Why?
|
| Gene Expression Regulation | 3 | 2011 | 12071 | 0.070 |
Why?
|
| Proportional Hazards Models | 1 | 2021 | 12344 | 0.070 |
Why?
|
| Cerebral Infarction | 1 | 1991 | 1007 | 0.070 |
Why?
|
| Cysteine | 1 | 2011 | 873 | 0.070 |
Why?
|
| Mass Screening | 1 | 2021 | 5238 | 0.070 |
Why?
|
| Oxidation-Reduction | 1 | 2011 | 2187 | 0.060 |
Why?
|
| Prevalence | 2 | 2019 | 15194 | 0.060 |
Why?
|
| Sleep | 2 | 2000 | 4604 | 0.060 |
Why?
|
| Calcinosis | 1 | 1994 | 1497 | 0.060 |
Why?
|
| Apoptosis | 1 | 2001 | 9715 | 0.060 |
Why?
|
| Binding Sites | 3 | 2011 | 6115 | 0.060 |
Why?
|
| Hybridomas | 1 | 1986 | 452 | 0.060 |
Why?
|
| Primary Health Care | 1 | 2021 | 4551 | 0.060 |
Why?
|
| Cross-Sectional Studies | 2 | 2023 | 24913 | 0.060 |
Why?
|
| Analysis of Variance | 1 | 2013 | 6365 | 0.060 |
Why?
|
| Gene Knockdown Techniques | 1 | 2008 | 1655 | 0.060 |
Why?
|
| Botulinum Toxins | 2 | 1997 | 192 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 1 | 2011 | 3847 | 0.060 |
Why?
|
| NADH Dehydrogenase | 1 | 2003 | 41 | 0.060 |
Why?
|
| Benzofurans | 1 | 1984 | 140 | 0.060 |
Why?
|
| Risk | 1 | 2016 | 9679 | 0.060 |
Why?
|
| Cohort Studies | 2 | 2023 | 40450 | 0.060 |
Why?
|
| Prazosin | 2 | 1979 | 96 | 0.050 |
Why?
|
| Functional Laterality | 2 | 2004 | 2290 | 0.050 |
Why?
|
| Receptors, Adrenergic | 3 | 1978 | 155 | 0.050 |
Why?
|
| Dementia | 1 | 1996 | 2501 | 0.050 |
Why?
|
| Neural Tube Defects | 1 | 2005 | 255 | 0.050 |
Why?
|
| Amiodarone | 1 | 1984 | 212 | 0.050 |
Why?
|
| Male | 24 | 2021 | 349538 | 0.050 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2019 | 8925 | 0.050 |
Why?
|
| Tetrodotoxin | 1 | 2003 | 258 | 0.050 |
Why?
|
| Hypothalamus | 2 | 1987 | 1063 | 0.050 |
Why?
|
| Cyclic AMP | 3 | 1993 | 1470 | 0.050 |
Why?
|
| Kinetics | 3 | 1995 | 6474 | 0.050 |
Why?
|
| Enzyme Inhibitors | 1 | 2012 | 3800 | 0.050 |
Why?
|
| Cell Adhesion Molecules | 1 | 2007 | 1599 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 3 | 1994 | 6313 | 0.050 |
Why?
|
| Diprenorphine | 2 | 1993 | 13 | 0.050 |
Why?
|
| Organ Culture Techniques | 1 | 2003 | 808 | 0.050 |
Why?
|
| Brain Ischemia | 1 | 1995 | 3258 | 0.050 |
Why?
|
| Pyrimidines | 1 | 2012 | 2933 | 0.050 |
Why?
|
| Pindolol | 2 | 1977 | 32 | 0.050 |
Why?
|
| Adult | 15 | 2021 | 213712 | 0.050 |
Why?
|
| Neuroblastoma | 4 | 1992 | 1225 | 0.050 |
Why?
|
| Tissue Distribution | 2 | 1995 | 2335 | 0.040 |
Why?
|
| Peripheral Nervous System Diseases | 2 | 1996 | 700 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2003 | 1723 | 0.040 |
Why?
|
| Neural Inhibition | 1 | 2004 | 598 | 0.040 |
Why?
|
| Aerosols | 1 | 2022 | 623 | 0.040 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2005 | 895 | 0.040 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 1984 | 633 | 0.040 |
Why?
|
| Thiamine | 1 | 1999 | 152 | 0.040 |
Why?
|
| Adolescent | 5 | 2019 | 85649 | 0.040 |
Why?
|
| RNA, Messenger | 4 | 2011 | 13029 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2019 | 35342 | 0.040 |
Why?
|
| DNA, Mitochondrial | 1 | 2003 | 814 | 0.040 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 1990 | 2099 | 0.040 |
Why?
|
| Phenylisopropyladenosine | 2 | 1988 | 14 | 0.040 |
Why?
|
| Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2018 | 56 | 0.040 |
Why?
|
| Carrier State | 1 | 2021 | 518 | 0.040 |
Why?
|
| Electromyography | 2 | 2000 | 1391 | 0.040 |
Why?
|
| Obesity | 1 | 2020 | 12705 | 0.040 |
Why?
|
| Hypokalemia | 1 | 1978 | 153 | 0.040 |
Why?
|
| Body Temperature | 1 | 2000 | 776 | 0.040 |
Why?
|
| Internationality | 1 | 2003 | 1002 | 0.040 |
Why?
|
| Paralysis | 1 | 1978 | 249 | 0.040 |
Why?
|
| Electroencephalography | 2 | 2004 | 6142 | 0.040 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 1998 | 482 | 0.040 |
Why?
|
| Middle Aged | 11 | 2021 | 213127 | 0.040 |
Why?
|
| Acetaldehyde | 1 | 1996 | 39 | 0.040 |
Why?
|
| Drug Interactions | 1 | 2001 | 1458 | 0.040 |
Why?
|
| Sampling Studies | 1 | 2018 | 623 | 0.040 |
Why?
|
| Cell Division | 2 | 1994 | 4564 | 0.030 |
Why?
|
| Metalloendopeptidases | 1 | 1998 | 396 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2020 | 11695 | 0.030 |
Why?
|
| Isoproterenol | 1 | 1976 | 399 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2011 | 8300 | 0.030 |
Why?
|
| Neurotransmitter Agents | 2 | 1996 | 647 | 0.030 |
Why?
|
| Behavior | 2 | 1979 | 560 | 0.030 |
Why?
|
| Quinazolines | 2 | 1979 | 1355 | 0.030 |
Why?
|
| Ambulatory Care Facilities | 1 | 2022 | 932 | 0.030 |
Why?
|
| Dystonia Musculorum Deformans | 1 | 1996 | 158 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2000 | 1907 | 0.030 |
Why?
|
| Cooperative Behavior | 1 | 2003 | 1503 | 0.030 |
Why?
|
| Cerebellar Cortex | 1 | 1996 | 107 | 0.030 |
Why?
|
| Angina Pectoris | 1 | 1979 | 977 | 0.030 |
Why?
|
| Immunoblotting | 1 | 1998 | 1683 | 0.030 |
Why?
|
| Neuronal Plasticity | 1 | 2004 | 1418 | 0.030 |
Why?
|
| Intra-Abdominal Fat | 1 | 2020 | 591 | 0.030 |
Why?
|
| Acetates | 1 | 1996 | 312 | 0.030 |
Why?
|
| Consensus | 1 | 2024 | 2935 | 0.030 |
Why?
|
| Stereotyped Behavior | 1 | 1975 | 136 | 0.030 |
Why?
|
| Saline Solution, Hypertonic | 1 | 1995 | 110 | 0.030 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 1996 | 491 | 0.030 |
Why?
|
| Learning | 1 | 2004 | 1705 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 17400 | 0.030 |
Why?
|
| Jews | 1 | 1996 | 385 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 1996 | 537 | 0.030 |
Why?
|
| Virulence Factors, Bordetella | 1 | 1993 | 156 | 0.030 |
Why?
|
| Reflex Sympathetic Dystrophy | 1 | 1994 | 58 | 0.030 |
Why?
|
| Maternal Behavior | 1 | 2016 | 311 | 0.030 |
Why?
|
| Pertussis Toxin | 1 | 1993 | 178 | 0.030 |
Why?
|
| Potassium Channels | 1 | 1996 | 562 | 0.030 |
Why?
|
| Sleep Deprivation | 1 | 2000 | 830 | 0.030 |
Why?
|
| RNA, Viral | 1 | 2022 | 2899 | 0.030 |
Why?
|
| Alcohol Amnestic Disorder | 1 | 1993 | 26 | 0.030 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2004 | 3760 | 0.030 |
Why?
|
| Olivopontocerebellar Atrophies | 1 | 1993 | 19 | 0.030 |
Why?
|
| Blotting, Northern | 1 | 1995 | 1581 | 0.030 |
Why?
|
| Mesencephalon | 2 | 1992 | 327 | 0.030 |
Why?
|
| Electrophysiology | 1 | 1996 | 1309 | 0.030 |
Why?
|
| Eponyms | 1 | 1992 | 15 | 0.030 |
Why?
|
| Disease Outbreaks | 1 | 2022 | 1768 | 0.030 |
Why?
|
| Drug Resistance | 1 | 1998 | 1608 | 0.030 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1993 | 821 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2021 | 77098 | 0.030 |
Why?
|
| Hippocampus | 1 | 2005 | 3661 | 0.030 |
Why?
|
| Movement | 2 | 1996 | 1470 | 0.030 |
Why?
|
| Injections | 1 | 1995 | 840 | 0.030 |
Why?
|
| Lyme Disease | 1 | 1998 | 618 | 0.030 |
Why?
|
| Hepatic Encephalopathy | 1 | 1993 | 139 | 0.030 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2019 | 1538 | 0.030 |
Why?
|
| Brain Injuries | 1 | 2004 | 2024 | 0.030 |
Why?
|
| Neurites | 1 | 1993 | 380 | 0.030 |
Why?
|
| Growth Substances | 1 | 1994 | 783 | 0.020 |
Why?
|
| Blood | 1 | 1994 | 598 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2000 | 6382 | 0.020 |
Why?
|
| Translocation, Genetic | 1 | 1996 | 1417 | 0.020 |
Why?
|
| Rats, Long-Evans | 1 | 2011 | 387 | 0.020 |
Why?
|
| Cerebellar Diseases | 1 | 1993 | 222 | 0.020 |
Why?
|
| Eye Movements | 1 | 1994 | 506 | 0.020 |
Why?
|
| Morphine | 1 | 1975 | 657 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2002 | 13814 | 0.020 |
Why?
|
| Multigene Family | 1 | 1994 | 1102 | 0.020 |
Why?
|
| Education, Graduate | 1 | 2011 | 81 | 0.020 |
Why?
|
| Peripheral Nerves | 1 | 1994 | 474 | 0.020 |
Why?
|
| Molecular Weight | 1 | 1992 | 2255 | 0.020 |
Why?
|
| Foot | 1 | 1994 | 528 | 0.020 |
Why?
|
| Physical Examination | 1 | 2016 | 1239 | 0.020 |
Why?
|
| Morphogenesis | 1 | 1994 | 752 | 0.020 |
Why?
|
| Antigens, Surface | 1 | 1994 | 1663 | 0.020 |
Why?
|
| Haplotypes | 1 | 1996 | 2781 | 0.020 |
Why?
|
| Protein Precursors | 1 | 1993 | 1154 | 0.020 |
Why?
|
| Time Factors | 5 | 1995 | 40054 | 0.020 |
Why?
|
| Physician's Role | 1 | 2016 | 942 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 2022 | 3527 | 0.020 |
Why?
|
| Glioma | 3 | 1992 | 3388 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 2 | 1998 | 9274 | 0.020 |
Why?
|
| Alprostadil | 1 | 1988 | 89 | 0.020 |
Why?
|
| Brain Diseases | 3 | 1992 | 1554 | 0.020 |
Why?
|
| Quality Control | 1 | 2011 | 841 | 0.020 |
Why?
|
| Zebrafish | 1 | 2020 | 2990 | 0.020 |
Why?
|
| Temperature | 1 | 1995 | 2207 | 0.020 |
Why?
|
| Hospitals | 1 | 2022 | 3937 | 0.020 |
Why?
|
| Drug Tolerance | 2 | 1984 | 375 | 0.020 |
Why?
|
| Biological Assay | 1 | 2011 | 652 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1992 | 2505 | 0.020 |
Why?
|
| Infant, Newborn | 2 | 2020 | 25575 | 0.020 |
Why?
|
| Cattle | 1 | 1994 | 3923 | 0.020 |
Why?
|
| Transfection | 1 | 1996 | 5892 | 0.020 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2019 | 2736 | 0.020 |
Why?
|
| Photochemistry | 1 | 2007 | 238 | 0.020 |
Why?
|
| Hydrogen Bonding | 1 | 2007 | 293 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2020 | 9735 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 1996 | 4742 | 0.020 |
Why?
|
| Diagnosis, Differential | 2 | 2016 | 12958 | 0.020 |
Why?
|
| Mothers | 1 | 2018 | 2163 | 0.020 |
Why?
|
| Policy | 1 | 2011 | 504 | 0.020 |
Why?
|
| Erythrocytes | 1 | 1976 | 2452 | 0.020 |
Why?
|
| Child | 4 | 2018 | 77478 | 0.020 |
Why?
|
| Enkephalin, Leucine-2-Alanine | 1 | 1986 | 9 | 0.020 |
Why?
|
| Etorphine | 1 | 1986 | 3 | 0.020 |
Why?
|
| Behavior, Animal | 1 | 1975 | 1882 | 0.020 |
Why?
|
| Enkephalin, Leucine | 1 | 1986 | 16 | 0.020 |
Why?
|
| Gastrula | 1 | 2006 | 84 | 0.020 |
Why?
|
| Molecular Conformation | 1 | 2007 | 563 | 0.020 |
Why?
|
| Neurosciences | 1 | 2011 | 347 | 0.020 |
Why?
|
| Disease Models, Animal | 3 | 2006 | 18006 | 0.020 |
Why?
|
| Efficiency, Organizational | 1 | 2011 | 695 | 0.020 |
Why?
|
| Transcription, Genetic | 2 | 1993 | 7721 | 0.020 |
Why?
|
| Cholera Toxin | 1 | 1988 | 553 | 0.020 |
Why?
|
| Dactinomycin | 1 | 1986 | 317 | 0.020 |
Why?
|
| Cycloheximide | 1 | 1986 | 347 | 0.020 |
Why?
|
| Behavior, Addictive | 1 | 2011 | 460 | 0.020 |
Why?
|
| Naloxone | 2 | 1986 | 367 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2000 | 14554 | 0.020 |
Why?
|
| Liver | 2 | 2020 | 7470 | 0.020 |
Why?
|
| Clone Cells | 1 | 1988 | 1692 | 0.020 |
Why?
|
| Blotting, Western | 1 | 1992 | 5180 | 0.020 |
Why?
|
| Immunoassay | 1 | 1988 | 752 | 0.020 |
Why?
|
| Child, Preschool | 2 | 2018 | 40955 | 0.020 |
Why?
|
| Embryo Culture Techniques | 1 | 2005 | 80 | 0.020 |
Why?
|
| Registries | 1 | 2020 | 8077 | 0.020 |
Why?
|
| Enkephalin, Methionine | 1 | 1983 | 26 | 0.020 |
Why?
|
| Up-Regulation | 1 | 1993 | 4211 | 0.020 |
Why?
|
| Cytoprotection | 1 | 2005 | 210 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2018 | 7770 | 0.010 |
Why?
|
| Astrocytes | 1 | 2011 | 1266 | 0.010 |
Why?
|
| Hybrid Cells | 1 | 1983 | 441 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 2016 | 6974 | 0.010 |
Why?
|
| Tremor | 1 | 1984 | 174 | 0.010 |
Why?
|
| Aged | 7 | 2022 | 162944 | 0.010 |
Why?
|
| Long-Term Potentiation | 1 | 2005 | 293 | 0.010 |
Why?
|
| Atrophy | 1 | 1987 | 1576 | 0.010 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2005 | 962 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 1992 | 6608 | 0.010 |
Why?
|
| Electron Transport | 1 | 2003 | 211 | 0.010 |
Why?
|
| Neutrophils | 1 | 1995 | 3711 | 0.010 |
Why?
|
| Eye | 1 | 2006 | 728 | 0.010 |
Why?
|
| Ataxia | 1 | 1984 | 304 | 0.010 |
Why?
|
| Neuropeptides | 1 | 2007 | 942 | 0.010 |
Why?
|
| Embryonic Development | 1 | 2006 | 704 | 0.010 |
Why?
|
| Leadership | 1 | 2011 | 1357 | 0.010 |
Why?
|
| Quality of Life | 1 | 2023 | 12730 | 0.010 |
Why?
|
| Narcotics | 1 | 1984 | 343 | 0.010 |
Why?
|
| Light | 1 | 2007 | 1374 | 0.010 |
Why?
|
| Pediatrics | 1 | 2016 | 3462 | 0.010 |
Why?
|
| Electric Stimulation | 2 | 2005 | 1770 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2016 | 14720 | 0.010 |
Why?
|
| Fetal Development | 1 | 2006 | 767 | 0.010 |
Why?
|
| Gene Expression | 1 | 1993 | 7790 | 0.010 |
Why?
|
| Sodium | 1 | 1986 | 1627 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 2007 | 2203 | 0.010 |
Why?
|
| Porphyrias | 1 | 1979 | 57 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 2003 | 1202 | 0.010 |
Why?
|
| Central Nervous System | 1 | 2006 | 1354 | 0.010 |
Why?
|
| Gelatinases | 1 | 1998 | 94 | 0.010 |
Why?
|
| Collagenases | 1 | 1998 | 228 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2007 | 3493 | 0.010 |
Why?
|
| Periodicity | 1 | 1978 | 363 | 0.010 |
Why?
|
| Adaptation, Physiological | 1 | 1984 | 1310 | 0.010 |
Why?
|
| Phenylhydrazines | 1 | 1976 | 28 | 0.010 |
Why?
|
| Haloperidol | 2 | 1977 | 397 | 0.010 |
Why?
|
| Affective Symptoms | 1 | 1979 | 407 | 0.010 |
Why?
|
| Benzyl Alcohols | 1 | 1976 | 29 | 0.010 |
Why?
|
| Receptors, Neurotransmitter | 1 | 1977 | 178 | 0.010 |
Why?
|
| Comorbidity | 1 | 2011 | 10372 | 0.010 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 1977 | 246 | 0.010 |
Why?
|
| Handwriting | 1 | 1996 | 28 | 0.010 |
Why?
|
| Membranes | 1 | 1976 | 173 | 0.010 |
Why?
|
| Age of Onset | 1 | 2003 | 3266 | 0.010 |
Why?
|
| Fluorides | 1 | 1976 | 126 | 0.010 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 1998 | 472 | 0.010 |
Why?
|
| Receptors, Drug | 1 | 1975 | 161 | 0.010 |
Why?
|
| Substance-Related Disorders | 1 | 2011 | 4250 | 0.010 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 1998 | 638 | 0.010 |
Why?
|
| Dextroamphetamine | 1 | 1975 | 129 | 0.010 |
Why?
|
| Infant | 1 | 2016 | 35070 | 0.010 |
Why?
|
| Injections, Intraperitoneal | 1 | 1975 | 424 | 0.010 |
Why?
|
| Evolution, Molecular | 1 | 2003 | 1937 | 0.010 |
Why?
|
| Cell Membrane | 1 | 1984 | 3744 | 0.010 |
Why?
|
| Neural Conduction | 1 | 1995 | 468 | 0.010 |
Why?
|
| Dietary Carbohydrates | 1 | 1978 | 904 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2011 | 19862 | 0.010 |
Why?
|
| Genes, Dominant | 1 | 1996 | 880 | 0.010 |
Why?
|
| Chromosome Disorders | 1 | 1996 | 515 | 0.010 |
Why?
|
| Aging | 1 | 2011 | 8626 | 0.010 |
Why?
|
| Diazepam | 1 | 1973 | 205 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 1994 | 39004 | 0.010 |
Why?
|
| Acute Disease | 2 | 1979 | 7141 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2003 | 3081 | 0.010 |
Why?
|
| Drinking | 1 | 1973 | 197 | 0.010 |
Why?
|
| Temporal Lobe | 1 | 1979 | 1669 | 0.010 |
Why?
|
| Taste | 1 | 1973 | 175 | 0.010 |
Why?
|
| DNA | 1 | 1986 | 7289 | 0.010 |
Why?
|
| Models, Biological | 1 | 2007 | 9581 | 0.010 |
Why?
|
| Syndrome | 2 | 1992 | 3248 | 0.010 |
Why?
|
| Cerebellar Ataxia | 1 | 1992 | 145 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1994 | 20086 | 0.010 |
Why?
|
| History, 19th Century | 1 | 1992 | 720 | 0.010 |
Why?
|
| Genetic Markers | 1 | 1996 | 2633 | 0.010 |
Why?
|
| Chromosome Aberrations | 1 | 1996 | 1811 | 0.010 |
Why?
|
| Movement Disorders | 1 | 1992 | 444 | 0.010 |
Why?
|
| Phentolamine | 2 | 1978 | 104 | 0.000 |
Why?
|
| Dopamine | 1 | 1975 | 1589 | 0.000 |
Why?
|
| DNA Mutational Analysis | 1 | 1996 | 4187 | 0.000 |
Why?
|
| Alzheimer Disease | 1 | 1987 | 7988 | 0.000 |
Why?
|
| Cannabis | 1 | 1973 | 432 | 0.000 |
Why?
|
| Polymorphism, Genetic | 1 | 1996 | 4328 | 0.000 |
Why?
|
| Electrocardiography | 1 | 1978 | 6440 | 0.000 |
Why?
|
| Motor Activity | 1 | 1975 | 2714 | 0.000 |
Why?
|
| Blood Pressure | 1 | 1979 | 8541 | 0.000 |
Why?
|
| Circadian Rhythm | 1 | 1975 | 2623 | 0.000 |
Why?
|
| Chronic Disease | 1 | 1998 | 9144 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 1987 | 57683 | 0.000 |
Why?
|
| Hypertension | 1 | 1979 | 8455 | 0.000 |
Why?
|
| Dihydroergotoxine | 1 | 1978 | 21 | 0.000 |
Why?
|
| Phenoxybenzamine | 1 | 1978 | 54 | 0.000 |
Why?
|
| Phenotype | 1 | 1996 | 16331 | 0.000 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 1978 | 174 | 0.000 |
Why?
|
| Clonidine | 1 | 1978 | 164 | 0.000 |
Why?
|
| Alprenolol | 1 | 1977 | 8 | 0.000 |
Why?
|
| Sotalol | 1 | 1977 | 49 | 0.000 |
Why?
|
| Quinuclidines | 1 | 1977 | 24 | 0.000 |
Why?
|
| Lysergic Acid Diethylamide | 1 | 1977 | 48 | 0.000 |
Why?
|
| Methods | 1 | 1977 | 1128 | 0.000 |
Why?
|
| Choline O-Acetyltransferase | 1 | 1977 | 150 | 0.000 |
Why?
|
| Glutamate Decarboxylase | 1 | 1977 | 246 | 0.000 |
Why?
|
| Propranolol | 1 | 1977 | 502 | 0.000 |
Why?
|
| Heart Failure | 1 | 1979 | 10856 | 0.000 |
Why?
|
| Iodine Radioisotopes | 1 | 1977 | 1030 | 0.000 |
Why?
|
| Brain Chemistry | 1 | 1977 | 981 | 0.000 |
Why?
|
| Solutions | 1 | 1973 | 426 | 0.000 |
Why?
|
| Serotonin | 1 | 1977 | 1024 | 0.000 |
Why?
|
| Osmolar Concentration | 1 | 1973 | 683 | 0.000 |
Why?
|
| Avoidance Learning | 1 | 1973 | 233 | 0.000 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 1977 | 1123 | 0.000 |
Why?
|
| Water | 1 | 1973 | 1388 | 0.000 |
Why?
|
| Myocardium | 1 | 1977 | 4775 | 0.000 |
Why?
|
| Motivation | 1 | 1973 | 1968 | 0.000 |
Why?
|
| Lung | 1 | 1977 | 9826 | 0.000 |
Why?
|